Coronary imaging technology developer Infraredx has begun a road show in advance of its upcoming initial public offering (IPO).
Infraredx plans to offer 4 million shares of its common stock, with underwriters receiving a 30-day option to buy an additional 600,000 shares, according to the firm. The company expects the IPO price will range from $13 to $15 per share.
RBC Capital Markets, Canaccord Genuity, and BMO Capital Markets are serving as joint book-running managers for the IPO, while Oppenheimer & Co. and BTIG are co-managers. The firm's shares are expected to trade on the Nasdaq Global Market under the symbol REDX.
